General
Opzelura (Ruxolitinib)
Virtual visit

Opzelura (Ruxolitinib)

With our quick and easy online prescription process, you can manage your health effortlessly — whether you need a first-time prescription for Opzelura (Ruxolitinib) or a refill of an existing one.

Licensed providers in all 50 states

Expert-guided, evidence-based treatments

Skip the trip to the doctor's office

Visit options

Costs shown are for the visit only. You'll pay for medication at your preferred pharmacy.

Video Visit

$25

Est. or $100 w/o insurance

Chat Visit

$30

w/o insurance

Most insurance accepted

Board-certified

No hidden fees

Available nationwide

What is Opzelura (Ruxolitinib)?

Opzelura is a prescription topical cream containing ruxolitinib, a JAK inhibitor used to treat atopic dermatitis (eczema) and vitiligo. It works by blocking JAK1 and JAK2 enzymes that drive the inflammatory and immune signaling responsible for these skin conditions. For eczema, it reduces the itch, redness, and inflammation of flares. For vitiligo, it helps repigment areas of skin that have lost their color due to immune destruction of melanocytes. It's applied twice daily to affected areas and represents a targeted, mechanism-specific approach to inflammatory skin disease.

JAK1/JAK2 inhibition

Blocks Janus kinase enzymes that transmit inflammatory cytokine signals within skin cells, interrupting the immune-driven inflammation and immune cell activation that cause both eczema flares and vitiligo depigmentation.

Itch and inflammation relief

By dampening the JAK-STAT signaling pathway in the skin, Opzelura rapidly reduces the intense itch, redness, and skin barrier disruption characteristic of atopic dermatitis flares.

Vitiligo repigmentation

For vitiligo, JAK inhibition helps reverse the immune attack on melanocytes and allows pigment-producing cells to recover and repopulate depigmented patches—a mechanism distinct from any previously available vitiligo treatment.

Virtual visit with clinician

Ongoing support, always available.

You’ll be supported by experienced clinicians who care for a wide range of health needs, from everyday concerns to more complex conditions.

Our clinicians track your progress over time and adjust your care as needed. If medication is prescribed, we’ll manage dosing and monitor for side effects. If lab testing is recommended, we review results and refine your plan accordingly. You’re never left to navigate care on your own.

All your care in one place. That’s the General Medicine difference.

We help you understand your options, connect you to the right clinicians, manage prescriptions, coordinate any needed evaluations, and keep an eye on your overall health along the way. It’s comprehensive care that looks at the full picture — your goals, your history, your lifestyle — and makes it simple to move forward with confidence.

Your care plan
Clinician

What our customers have to say

“I feel like I’m finally on the right path to improving my health with the right support now! It’s so refreshing and reassuring.”

Emerald

“My experience with General Medicine was amazing. The understanding and care that was taken to figure out what is exactly going on with me. I feel like a weight has been lifted off of me.”

Kaylee

“I couldn’t be happier with my experience with General Medicine! They are fast, responsive, kind and knowledgeable. It is much easier, more affordable and faster.”

Nika

Get the care you need, without the wait.

Frequently Asked Questions

How quickly does Opzelura work for eczema?

Many people notice significant itch relief within the first 1–2 weeks of twice-daily use. Visible skin improvement in redness and lesions typically develops over 4–8 weeks of consistent application.

How is Opzelura different from topical steroids?

Opzelura works through a non-steroidal mechanism — blocking JAK enzymes that drive inflammation. This means it can be used on sensitive areas without the skin-thinning risks associated with long-term topical corticosteroid use.

Can Opzelura be used for both eczema and vitiligo?

Yes. Opzelura is FDA-approved for both atopic dermatitis and vitiligo — treating eczema inflammation and helping repigment areas affected by vitiligo through the same JAK-inhibiting mechanism.

What side effects might I experience?

Local application site reactions — burning, stinging, and redness — are most common. Because some ruxolitinib is absorbed systemically, there is a small increase in infection risk with larger treatment areas.

Is there a limit to how much skin area I can treat?

Yes. Treatment should be limited to no more than 20% of body surface area to limit systemic absorption. Your clinician will advise on the appropriate area to treat based on your condition.
Logo

© 2026 Path Healthcare Systems Corp.